Hatteras Venture Partners
Hatteras Venture Partners is a venture capital firm with over two decades of experience investing in early-stage healthcare companies. Their focus is on building transformational human medicine companies and disrupting the status quo in healthcare through transformative therapies and disruptive technologies.
📥 Buy Full VC Dataset
Offices: Durham (United States)
Investment Stages: Seed, Series A, Series B
Markets: Biopharma, Med Devices, Diagnostics, Healthcare IT
Founded Year: 2000
Investor Type: Venture Capital
Portfolio Companies: Tune Therapeutics, Atacor Medical, Iris Healthcare, Atsena, StrideBio, G1 Therapeutics, Elligo Health Research, Ribometrix, Contego Medical, Standard Bariatrics, Rodin, Ribometrix, NurseGrid, GreyBug Inc, Qpex SpineAlign, Trefoil Therapeuitics, Inc, Wildflower Health Inc, Dropworks, Artizan Biosciences, Inc, BlinkBio (fka Coferon Inc), Clearside Biomedical, Boston Immune Technologies, Curoverse Inc, Genturi, Inc, Kymera Lysosomal Therapeutics Inc, ORIG3N Inc, Rodin Therapeutics, Inc, Sideris Pharmaceuticals Inc, HistoSonics, ArtusLabs, Bivarus, Inc, CancerGuide Diagnostics, Clinipace, Clinverse Inc, Contego Medical LLC, Entegrion, G1 Therapeutics Inc, GeneCentric, Innocrin Pharmaceuticals, KinoDyn Inc, Medfusion, Inc, NeuroTronik Inc, Respirics, Ribometrix, Inc, Spyryx Biosciences Inc, StrideBio, Inc, Viamet Pharmaceuticals, Medikidz Inc, Standard Bariatrics, Inc, NurseGrid, Embrella Cardiovascular, PhaseBio Pharmaceuticals, TetraLogic, Device Innovation Group, NuSirt Biopharma Inc, Pathfinder, Elligo Health Research, Inc, Qvella Corporation
Website: https://www.hatterasvp.com
Team Page: https://www.hatterasvp.com/team/
Portfolio Link: https://www.hatterasvp.com/portfolio/
LinkedIn: https://www.linkedin.com/company/hatteras-venture-partners/
Crunchbase: https://www.crunchbase.com/organization/hatteras-venture-partners
Comments
No comments yet. Be the first to comment!